We are live on ! Find out more
ASMB icon

Assembly Biosciences

57 hedge funds and large institutions have $232M invested in Assembly Biosciences in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 13 increasing their positions, 6 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

288% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 8

117% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 6

68% more funds holding

Funds holding: 3457 (+23)

63% more capital invested

Capital invested by funds: $143M → $232M (+$89.7M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
57
Holders Change
+23
Holders Change %
+67.65%
% of All Funds
1.54%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
31
Increased
13
Reduced
6
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Jennison Associates
1
Jennison Associates
New York
$38.7M +$211K +1,096 +0.7%
EC
2
EcoR1 Capital
California
$30.3M
VAM
3
Visium Asset Management
New York
$28.9M
O
4
OrbiMed
New York
$26.9M +$757K +3,925 +3%
PA
5
Perceptive Advisors
New York
$15.1M +$5.79M +29,991 +85%
QF
6
QVT Financial
New York
$10.3M
HM
7
HealthCor Management
New York
$9.73M +$488K +2,531 +6%
BFA
8
BlackRock Fund Advisors
California
$7.28M +$6.08M +31,499 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.28M +$1.02M +5,277 +20%
PI
10
Putnam Investments
Massachusetts
$7.13M
BIT
11
BlackRock Institutional Trust
California
$6.87M +$1.42M +7,359 +33%
Millennium Management
12
Millennium Management
New York
$6.4M -$1.12M -5,808 -17%
RSCM
13
Rock Springs Capital Management
Maryland
$6.04M -$64.3K -333 -1%
BBA
14
Baker Bros. Advisors
New York
$4.82M
Fidelity Investments
15
Fidelity Investments
Massachusetts
$4.06M +$1.78M +9,225 +111%
IHM
16
Iguana Healthcare Management
New York
$3.37M +$402K +2,083 +17%
GTC
17
Ghost Tree Capital
New York
$3.37M +$804K +4,166 +40%
State Street
18
State Street
Massachusetts
$2.27M +$1.89M +9,805 New
Geode Capital Management
19
Geode Capital Management
Massachusetts
$1.59M +$392K +2,029 +42%
OPPM
20
Opus Point Partners Management
New York
$1.25M
GGHC
21
Gilder Gagnon Howe & Co
New York
$1.19M +$991K +5,135 New
BIM
22
Bogle Investment Management
Massachusetts
$1.1M +$922K +4,776 New
BIM
23
BlackRock Investment Management
Delaware
$977K +$816K +4,227 New
Bank of New York Mellon
24
Bank of New York Mellon
New York
$938K +$783K +4,058 New
Northern Trust
25
Northern Trust
Illinois
$660K +$551K +2,854 New

ASMB Hedge Fund Activity: Q2 2015 in Review

57 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2015, worth a combined $232M — up 63% from $143M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new ASMB positions and 8 closed out — a net gain of 23 holders — while 13 added to existing stakes and 6 trimmed.

The largest buyer was BlackRock Fund Advisors, opening a new position worth an estimated $6.08M. The largest seller was RTW Investments, exiting entirely with an estimated $2.7M sold.

  • 57 institutional investors held Assembly Biosciences (ASMB) as of Q2 2015, up from 34 in Q1 2015.
  • Funds reported $232M of Assembly Biosciences stock for Q2 2015, up 63% quarter-over-quarter.
  • 31 funds opened new Assembly Biosciences positions in Q2 2015 and 8 closed out, a net change of +23 holders.
  • The largest Assembly Biosciences buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $6.08M added.
  • The largest Assembly Biosciences seller in Q2 2015 was RTW Investments, an estimated $2.7M sold.

Based on aggregated 13F filings for Q2 2015.